JPH0566103B2 - - Google Patents
Info
- Publication number
- JPH0566103B2 JPH0566103B2 JP6907885A JP6907885A JPH0566103B2 JP H0566103 B2 JPH0566103 B2 JP H0566103B2 JP 6907885 A JP6907885 A JP 6907885A JP 6907885 A JP6907885 A JP 6907885A JP H0566103 B2 JPH0566103 B2 JP H0566103B2
- Authority
- JP
- Japan
- Prior art keywords
- cells
- polymer
- cell
- column
- affinity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229920000642 polymer Polymers 0.000 claims description 38
- 239000000126 substance Substances 0.000 claims description 26
- 238000000034 method Methods 0.000 claims description 22
- 238000001179 sorption measurement Methods 0.000 claims description 10
- 239000003550 marker Substances 0.000 claims description 8
- 210000004027 cell Anatomy 0.000 description 76
- 210000004698 lymphocyte Anatomy 0.000 description 17
- 210000001744 T-lymphocyte Anatomy 0.000 description 15
- 238000000926 separation method Methods 0.000 description 13
- 239000012981 Hank's balanced salt solution Substances 0.000 description 12
- 210000003719 b-lymphocyte Anatomy 0.000 description 11
- 239000011324 bead Substances 0.000 description 11
- 125000000524 functional group Chemical group 0.000 description 11
- 239000011521 glass Substances 0.000 description 10
- 238000002955 isolation Methods 0.000 description 10
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 8
- 239000012091 fetal bovine serum Substances 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 239000006285 cell suspension Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 241000283707 Capra Species 0.000 description 5
- 230000027455 binding Effects 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 239000008363 phosphate buffer Substances 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 108060003951 Immunoglobulin Proteins 0.000 description 4
- 108090001090 Lectins Proteins 0.000 description 4
- 102000004856 Lectins Human genes 0.000 description 4
- 229920001577 copolymer Polymers 0.000 description 4
- 102000018358 immunoglobulin Human genes 0.000 description 4
- 239000002523 lectin Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 238000001042 affinity chromatography Methods 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 210000001165 lymph node Anatomy 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 238000004091 panning Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- KANZWHBYRHQMKZ-UHFFFAOYSA-N 2-ethenylpyrazine Chemical compound C=CC1=CN=CC=N1 KANZWHBYRHQMKZ-UHFFFAOYSA-N 0.000 description 2
- VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical compound NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108090001008 Avidin Proteins 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 2
- 238000003320 cell separation method Methods 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000003234 fluorescent labeling method Methods 0.000 description 2
- 229920000578 graft copolymer Polymers 0.000 description 2
- 229940072221 immunoglobulins Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 2
- 210000000207 lymphocyte subset Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229920000768 polyamine Polymers 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000002336 sorption--desorption measurement Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- IJSCYIZQNHIKIU-UHFFFAOYSA-N 2-ethenyl-1,3-dihydropyrazole Chemical compound C=CN1CC=CN1 IJSCYIZQNHIKIU-UHFFFAOYSA-N 0.000 description 1
- MLMGJTAJUDSUKA-UHFFFAOYSA-N 2-ethenyl-1h-imidazole Chemical compound C=CC1=NC=CN1 MLMGJTAJUDSUKA-UHFFFAOYSA-N 0.000 description 1
- XUGNJOCQALIQFG-UHFFFAOYSA-N 2-ethenylquinoline Chemical compound C1=CC=CC2=NC(C=C)=CC=C21 XUGNJOCQALIQFG-UHFFFAOYSA-N 0.000 description 1
- ROHTVIURAJBDES-UHFFFAOYSA-N 2-n,2-n-bis(prop-2-enyl)-1,3,5-triazine-2,4,6-triamine Chemical compound NC1=NC(N)=NC(N(CC=C)CC=C)=N1 ROHTVIURAJBDES-UHFFFAOYSA-N 0.000 description 1
- UWRZIZXBOLBCON-UHFFFAOYSA-N 2-phenylethenamine Chemical compound NC=CC1=CC=CC=C1 UWRZIZXBOLBCON-UHFFFAOYSA-N 0.000 description 1
- KGIGUEBEKRSTEW-UHFFFAOYSA-N 2-vinylpyridine Chemical compound C=CC1=CC=CC=N1 KGIGUEBEKRSTEW-UHFFFAOYSA-N 0.000 description 1
- UMKWZZPKADNTRP-UHFFFAOYSA-N 4-ethenylpyrimidine Chemical compound C=CC1=CC=NC=N1 UMKWZZPKADNTRP-UHFFFAOYSA-N 0.000 description 1
- MHQZDNQHLGFBRN-UHFFFAOYSA-N 5-ethenyl-1h-imidazole Chemical compound C=CC1=CNC=N1 MHQZDNQHLGFBRN-UHFFFAOYSA-N 0.000 description 1
- YOQXWFAPUCIKIH-UHFFFAOYSA-N 5-ethenyl-2-ethylpyridine Chemical compound CCC1=CC=C(C=C)C=N1 YOQXWFAPUCIKIH-UHFFFAOYSA-N 0.000 description 1
- VJOWMORERYNYON-UHFFFAOYSA-N 5-ethenyl-2-methylpyridine Chemical compound CC1=CC=C(C=C)C=N1 VJOWMORERYNYON-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
- 238000011725 BALB/c mouse Methods 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 210000001239 CD8-positive, alpha-beta cytotoxic T lymphocyte Anatomy 0.000 description 1
- 102000000844 Cell Surface Receptors Human genes 0.000 description 1
- 108010001857 Cell Surface Receptors Proteins 0.000 description 1
- 108010062580 Concanavalin A Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000009109 Fc receptors Human genes 0.000 description 1
- 108010087819 Fc receptors Proteins 0.000 description 1
- 102000000588 Interleukin-2 Human genes 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 102000008072 Lymphokines Human genes 0.000 description 1
- 108010074338 Lymphokines Proteins 0.000 description 1
- VKXAZYJXZCLFEI-UHFFFAOYSA-N N,N-diethyl-2-phenylbut-3-en-1-amine Chemical compound C(C)N(CC)CC(C1=CC=CC=C1)C=C VKXAZYJXZCLFEI-UHFFFAOYSA-N 0.000 description 1
- -1 N,N-diethyl-N'-(p-vinylphenethyl)ethylenediamine Chemical compound 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108010046016 Peanut Agglutinin Proteins 0.000 description 1
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Natural products C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000005576 amination reaction Methods 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium group Chemical group [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 238000010539 anionic addition polymerization reaction Methods 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 102000023732 binding proteins Human genes 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000004581 coalescence Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 238000006704 dehydrohalogenation reaction Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002900 effect on cell Effects 0.000 description 1
- UYMKPFRHYYNDTL-UHFFFAOYSA-N ethenamine Chemical compound NC=C UYMKPFRHYYNDTL-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000002443 helper t lymphocyte Anatomy 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- CJIPLMHXHKPZGM-UHFFFAOYSA-N n,n-bis(prop-2-enyl)aniline Chemical compound C=CCN(CC=C)C1=CC=CC=C1 CJIPLMHXHKPZGM-UHFFFAOYSA-N 0.000 description 1
- DPLUMPJQXVYXBH-UHFFFAOYSA-N n,n-diethyl-2-phenylethenamine Chemical compound CCN(CC)C=CC1=CC=CC=C1 DPLUMPJQXVYXBH-UHFFFAOYSA-N 0.000 description 1
- UQADNXUWLBEGLY-UHFFFAOYSA-N n,n-diethyl-4-phenylbut-3-en-1-amine Chemical compound CCN(CC)CCC=CC1=CC=CC=C1 UQADNXUWLBEGLY-UHFFFAOYSA-N 0.000 description 1
- BSMUCYCEQAPGBW-UHFFFAOYSA-N n,n-dimethyl-2-phenylbut-3-en-1-amine Chemical compound CN(C)CC(C=C)C1=CC=CC=C1 BSMUCYCEQAPGBW-UHFFFAOYSA-N 0.000 description 1
- SDYRIBONPHEWCT-UHFFFAOYSA-N n,n-dimethyl-2-phenylethenamine Chemical compound CN(C)C=CC1=CC=CC=C1 SDYRIBONPHEWCT-UHFFFAOYSA-N 0.000 description 1
- GBCKRQRXNXQQPW-UHFFFAOYSA-N n,n-dimethylprop-2-en-1-amine Chemical compound CN(C)CC=C GBCKRQRXNXQQPW-UHFFFAOYSA-N 0.000 description 1
- ZUSCWVCVASRXOO-UHFFFAOYSA-N n-(2-phenylethyl)pent-1-en-1-amine Chemical compound CCCC=CNCCC1=CC=CC=C1 ZUSCWVCVASRXOO-UHFFFAOYSA-N 0.000 description 1
- BVWUEIUNONATML-UHFFFAOYSA-N n-benzylethenamine Chemical compound C=CNCC1=CC=CC=C1 BVWUEIUNONATML-UHFFFAOYSA-N 0.000 description 1
- XEMKKDUUJABFSE-UHFFFAOYSA-N n-ethenyl-2-phenylethanamine Chemical compound C=CNCCC1=CC=CC=C1 XEMKKDUUJABFSE-UHFFFAOYSA-N 0.000 description 1
- MJUXRARMNNVUNK-UHFFFAOYSA-N n-phenylethenimine Chemical compound C=C=NC1=CC=CC=C1 MJUXRARMNNVUNK-UHFFFAOYSA-N 0.000 description 1
- DYUWTXWIYMHBQS-UHFFFAOYSA-N n-prop-2-enylprop-2-en-1-amine Chemical compound C=CCNCC=C DYUWTXWIYMHBQS-UHFFFAOYSA-N 0.000 description 1
- KKFHAJHLJHVUDM-UHFFFAOYSA-N n-vinylcarbazole Chemical compound C1=CC=C2N(C=C)C3=CC=CC=C3C2=C1 KKFHAJHLJHVUDM-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000007151 ring opening polymerisation reaction Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000006557 surface reaction Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 229920003176 water-insoluble polymer Polymers 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6907885A JPS61227798A (ja) | 1985-04-03 | 1985-04-03 | 細胞の分離法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6907885A JPS61227798A (ja) | 1985-04-03 | 1985-04-03 | 細胞の分離法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61227798A JPS61227798A (ja) | 1986-10-09 |
| JPH0566103B2 true JPH0566103B2 (cs) | 1993-09-21 |
Family
ID=13392187
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP6907885A Granted JPS61227798A (ja) | 1985-04-03 | 1985-04-03 | 細胞の分離法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61227798A (cs) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3132092T (pt) * | 2014-04-16 | 2019-12-18 | Solenis Tech Lp | Polímeros contendo vinilamina modificada e sua utilização no fabrico de papel |
| JP2019000063A (ja) * | 2017-06-19 | 2019-01-10 | 東ソー株式会社 | 未分化細胞の剥離回収方法 |
-
1985
- 1985-04-03 JP JP6907885A patent/JPS61227798A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS61227798A (ja) | 1986-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7439062B2 (en) | Beads for capturing target cells from bodily fluid | |
| Haas et al. | Separation of antigen-specific lymphocytes. I. Enrichment of antigen-binding cells. | |
| US20210115401A1 (en) | Methods and Materials for the Generation of Regulatory T Cells | |
| Wigzell et al. | Separation of cells according to surface antigens by the use of antibody‐coated columns. Fractionation of cells carrying immunoglobulins and blood group antigen | |
| Alarcon-Segovia et al. | Antibody to nuclear ribonucleoprotein penetrates live human mononuclear cells through Fc receptors | |
| Brown et al. | Cell surface markers for human T and B lymphocytes | |
| US4035316A (en) | Cell specific, variable density, polymer microspheres | |
| JP2721040B2 (ja) | 粒子表面からリガンドを除去するための方法 | |
| JPS597265A (ja) | リンパ球群中のｂ細胞及びｔ細胞の相対量の同時測定方法 | |
| JPH0361480A (ja) | アフィニティーマトリックスからの細胞の解離 | |
| WO2020154038A1 (en) | Crosslinked polysaccharide based absorbents for removal of anti-a and/or anti-b antibodies from human plasma and whole blood | |
| CN1141582C (zh) | 用二氢唑酮功能化载体选择完整细胞的方法 | |
| Kataoka et al. | Immunoaffinity chromatography of lymphocyte subpopulations using tert-amine derived matrices with adsorbed antibodies | |
| JP3441496B2 (ja) | アフィニティー分離材料 | |
| JPH08103653A (ja) | 刺激応答型分離材料及びその製造方法 | |
| JPH0566103B2 (cs) | ||
| Zeijlemaker et al. | Human lymphocyte subpopulations involved in MLC and CML | |
| Campbell et al. | Immunoadsorbents-Preparation and use of cellulose derivatives | |
| Margel | Agarose-polyaldehyde microsphere beads: Synthesis and biomedical applications: Cell labeling, cell separation, affinity chromatography, and hemoperfusion | |
| JPH0558707B2 (cs) | ||
| FI72822B (fi) | Immunologisk reagens foer bestaemning av graviditet, foerfarande foer framstaellning av detta och foerfarande foer bestaemning av graviditet. | |
| Muramatsu et al. | Platelet adhesion onto artificial red blood cells | |
| JP2004045120A (ja) | 液体クロマトグラフ用カラム材料 | |
| JPS59135887A (ja) | 生理活性物質固定化用担体 | |
| JP2631483B2 (ja) | Ｔ細胞、ｂ細胞の分離採取方法および装置 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Cancellation because of no payment of annual fees |